Sickle-Cell Anemia Therapeutics Market in the US 2018-2022

Published: Dec 2018 Pages: 75 SKU: IRTNTR21333

Below are some of the key findings from the market analysis for sickle-cell anemia therapeutics in the US:

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

  

Industry Overview for Sickle-cell Anemia Therapeutics Market in the US

The treatment for sickle-cell anemia requires high-cost medications. Several companies and government organizations are making efforts to reduce the treatment burden on patients by establishing reimbursement policies. For instance, in 2018, Emmaus Medical announced that it had signed a Medicaid Drug Rebate Agreement with the Centers for Medicare and Medicaid Services allowing coverage of Endari. The availability of favorable reimbursement for sickle-cell anemia therapeutics is one of the critical reasons that will propel the sickle-cell anemia therapeutics market in the US in the next five years.

Special drug designations such as orphan drug designations for sickle-cell anemia will drive the sickle-cell anemia therapeutics market in the US to grow at a CAGR of over 15% during the forecast period. There are very few products available in the US for the treatment of sickle-cell anemia. Hence, recently approved drugs will drive market growth.

Top US sickle-cell anemia therapeutics companies covered in this market research report

The sickle-cell anemia therapeutics market in the US is highly concentrated. Market players are leveraging advanced technologies to offer effective sickle-cell anemia therapeutics. By providing a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this industry analysis report for sickle-cell anemia therapeutics market in the US will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.

The report offers a complete analysis of various companies including:

  • Bristol-Myers Squibb
  • Emmaus Medical
  • Medunik USA

The US Sickle-cell anemia therapeutics market segmentation based on therapy

  •  Hydroxyurea
  • L-glutamine therapy

The hydroxyurea segment will account for the highest market share of the sickle-cell anemia therapeutics market in the US as hydroxyurea helps in increasing the level of hemoglobin in the body.

Key highlights of the sickle-cell anemia therapeutics market in the US for the forecast years 2018-2022:

  • CAGR of the market during the forecast period 2018-2022
  • Detailed information on factors that will accelerate the growth of the sickle-cell anemia therapeutics market in the US during the next five years
  • Precise estimation of the market size for sickle-cell anemia therapeutics in the US and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the US sickle-cell anemia therapeutics industry across various geographies such as the US
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of the US sickle-cell anemia therapeutics companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY THERAPY

  • Segmentation by therapy
  • Comparison by therapy
  • Hydroxyurea – Market size and forecast 2017-2022
  • L-glutamine therapy– Market size and forecast 2017-2022
  • Market opportunity by therapy

PART 08: CUSTOMER LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Introduction of gene therapy
  • Strategic alliances
  • Orphan drug designations for sickle-cell anemia

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb
  • Emmaus Medical
  • Medunik USA

PART 14: APPENDIX

  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis